ClearBridge Investments’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $792M | Sell |
1,610,697
-252,029
| -14% | -$137M | 0.69% | 28 |
|
|
2025
Q4 | $1.08B | Sell |
1,862,726
-104,802
| -5% | -$59.3M | 0.86% | 18 |
|
|
2025
Q3 | $954M | Buy |
1,967,528
+546,587
| +38% | +$254M | 0.72% | 27 |
|
|
2025
Q2 | $576M | Sell |
1,420,941
-241,924
| -15% | -$101M | 0.47% | 60 |
|
|
2025
Q1 | $827M | Sell |
1,662,865
-188,324
| -10% | -$102M | 0.72% | 26 |
|
|
2024
Q4 | $963M | Sell |
1,851,189
-242,394
| -12% | -$133M | 0.78% | 19 |
|
|
2024
Q3 | $1.3B | Sell |
2,093,583
-4,499
| -0.2% | -$2.66M | 1.02% | 12 |
|
|
2024
Q2 | $1.16B | Sell |
2,098,082
-138,694
| -6% | -$79.5M | 0.94% | 13 |
|
|
2024
Q1 | $1.3B | Buy |
2,236,776
+8,046
| +0.4% | +$4.51M | 1.03% | 12 |
|
|
2023
Q4 | $1.18B | Buy |
2,228,730
+553,695
| +33% | +$268M | 1.02% | 12 |
|
|
2023
Q3 | $848M | Buy |
1,675,035
+51,113
| +3% | +$27.2M | 0.82% | 17 |
|
|
2023
Q2 | $847M | Sell |
1,623,922
-156,773
| -9% | -$84.6M | 0.76% | 23 |
|
|
2023
Q1 | $1.03B | Sell |
1,780,695
-293,587
| -14% | -$165M | 0.98% | 15 |
|
|
2022
Q4 | $1.14B | Sell |
2,074,282
-564,175
| -21% | -$299M | 1.13% | 10 |
|
|
2022
Q3 | $1.34B | Sell |
2,638,457
-108,005
| -4% | -$60.4M | 1.35% | 8 |
|
|
2022
Q2 | $1.49B | Sell |
2,746,462
-27,074
| -1% | -$14.9M | 1.39% | 9 |
|
|
2022
Q1 | $1.64B | Sell |
2,773,536
-29,979
| -1% | -$17.2M | 1.23% | 11 |
|
|
2021
Q4 | $1.87B | Sell |
2,803,515
-86,816
| -3% | -$54.2M | 1.27% | 11 |
|
|
2021
Q3 | $1.65B | Sell |
2,890,331
-66,214
| -2% | -$36.3M | 1.18% | 14 |
|
|
2021
Q2 | $1.49B | Buy |
2,956,545
+24,684
| +0.8% | +$11.6M | 1.04% | 17 |
|
|
2021
Q1 | $1.34B | Sell |
2,931,861
-182,947
| -6% | -$87.3M | 1% | 17 |
|
|
2020
Q4 | $1.45B | Sell |
3,114,808
-140,353
| -4% | -$65.8M | 1.12% | 14 |
|
|
2020
Q3 | $1.44B | Sell |
3,255,161
-200,815
| -6% | -$83M | 1.24% | 14 |
|
|
2020
Q2 | $1.25B | Buy |
3,455,976
+49,214
| +1% | +$16.5M | 1.13% | 15 |
|
|
2020
Q1 | $966M | Sell |
3,406,762
-2,526
| -0.1% | -$797K | 1.05% | 17 |
|
|
2019
Q4 | $1.11B | Buy |
3,409,288
+13,078
| +0.4% | +$3.97M | 0.92% | 19 |
|
|
2019
Q3 | $989M | Buy |
3,396,210
+268,846
| +9% | +$77M | 0.86% | 28 |
|
|
2019
Q2 | $918M | Buy |
3,127,364
+38,169
| +1% | +$10.5M | 0.8% | 31 |
|
|
2019
Q1 | $846M | Buy |
3,089,195
+71,898
| +2% | +$17.9M | 0.75% | 31 |
|
|
2018
Q4 | $675M | Buy |
3,017,297
+39,966
| +1% | +$9.38M | 0.68% | 32 |
|
|
2018
Q3 | $727M | Sell |
2,977,331
-12,419
| -0.4% | -$2.86M | 0.63% | 35 |
|
|
2018
Q2 | $619M | Buy |
2,989,750
+57,623
| +2% | +$12.2M | 0.51% | 47 |
|
|
2018
Q1 | $605M | Buy |
2,932,127
+69,728
| +2% | +$14.6M | 0.57% | 44 |
|
|
2017
Q4 | $544M | Buy |
2,862,399
+143,518
| +5% | +$27.5M | 0.5% | 60 |
|
|
2017
Q3 | $514M | Buy |
2,718,881
+75,735
| +3% | +$13.7M | 0.49% | 57 |
|
|
2017
Q2 | $461M | Buy |
2,643,146
+71,363
| +3% | +$12M | 0.45% | 60 |
|
|
2017
Q1 | $395M | Buy |
2,571,783
+365,409
| +17% | +$55.9M | 0.4% | 68 |
|
|
2016
Q4 | $311M | Buy |
2,206,374
+233,092
| +12% | +$34.4M | 0.34% | 91 |
|
|
2016
Q3 | $314M | Buy |
1,973,282
+103,761
| +6% | +$16M | 0.35% | 84 |
|
|
2016
Q2 | $276M | Buy |
1,869,521
+99,588
| +6% | +$14.7M | 0.33% | 85 |
|
|
2016
Q1 | $251M | Buy |
1,769,933
+58,316
| +3% | +$7.82M | 0.3% | 91 |
|
|
2015
Q4 | $243M | Buy |
1,711,617
+92,303
| +6% | +$12.3M | 0.28% | 95 |
|
|
2015
Q3 | $198M | Sell |
1,619,314
-2,420
| -0.1% | -$315K | 0.24% | 119 |
|
|
2015
Q2 | $210M | Sell |
1,621,734
-27,761
| -2% | -$3.62M | 0.22% | 124 |
|
|
2015
Q1 | $222M | Buy |
1,649,495
+19,713
| +1% | +$2.54M | 0.23% | 121 |
|
|
2014
Q4 | $204M | Sell |
1,629,782
-2,244
| -0.1% | -$273K | 0.21% | 125 |
|
|
2014
Q3 | $199M | Sell |
1,632,026
-7,048
| -0.4% | -$857K | 0.22% | 123 |
|
|
2014
Q2 | $193M | Sell |
1,639,074
-22,607
| -1% | -$2.66M | 0.22% | 123 |
|
|
2014
Q1 | $200M | Sell |
1,661,681
-201,430
| -11% | -$23.9M | 0.24% | 116 |
|
|
2013
Q4 | $207M | Buy |
1,863,111
+12,739
| +0.7% | +$1.27M | 0.26% | 115 |
|
|
2013
Q3 | $171M | Sell |
1,850,372
-229,492
| -11% | -$20.8M | 0.24% | 120 |
|
|
2013
Q2 | $176M | Buy |
+2,079,864
| New | +$173M | 0.27% | 110 |
|
Other funds holding TMO
VCM
ClearBridge Investments's TMO Position: Q1 2026 in Review
ClearBridge Investments reduced its Thermo Fisher Scientific (TMO) stake by 14% in Q1 2026, selling an estimated $137M and leaving 1,610,697 shares worth $792M. The position accounts for 0.69% of the portfolio, ranked #28.
ClearBridge Investments first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.87B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- ClearBridge Investments held 1,610,697 shares of Thermo Fisher Scientific worth $792M as of Q1 2026.
- ClearBridge Investments sold 252,029 Thermo Fisher Scientific shares in Q1 2026, an estimated $137M.
- Thermo Fisher Scientific made up 0.69% of ClearBridge Investments's portfolio in Q1 2026, its #28 holding.
- ClearBridge Investments first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- ClearBridge Investments's Thermo Fisher Scientific position peaked at $1.87B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on ClearBridge Investments's 13F filing for Q1 2026, filed 13 May 2026.